Table 2

Schemes for stratification of stroke risk in non-valvar atrial fibrillation

High riskModerate riskLow risk
Untreated patients
Atrial Fibrillation Investigators (1994)11 Age ⩾ 65 years
History of hypertension
Diabetes
Prior stroke/TIA
Age < 65 years
No high risk features
 Observed stroke rate5.1%/yearNA1.0%/year
American College of Chest Physicians Consensus (1998)14 Age > 75 years
History of hypertension
Prior stroke/TIA
Left ventricular dysfunction2-150
> 1 moderate risk factor
Age 65-75 years
Diabetes
Coronary disease
Thyrotoxicosis
Age < 65 years
No risk factors
 Observed stroke rateNANANA
Aspirin treated patients
Stroke Prevention in Atrial Fibrillation (1995)12 Women > 75 years
Systolic BP > 160 mm Hg
Prior stroke/TIA
Left ventricular dysfunction2-151
History of hypertension
No high risk features
No high risk features
No history of hypertension
 Observed stroke rate7.7%/year3.6%/year1.1%/year
SPAF Exploratory Analysis (1999)13 Women > 75 years
Systolic > 160 mm Hg
Hypertension plus age > 75
Prior stroke/TIA
Hypertension and
 age ⩽ 75 years
Diabetes
No high risk features
No high or moderate risk features
 Observed stroke rate7.1%/year2.6%/year0.9%/year
  • 2-150 Moderate to severe left ventricular systolic dysfunction on echocardiography or recent congestive heart failure.

  • 2-151 Impaired left ventricular function included recent congestive heart failure or fractional shortening ⩽ 25% by M mode echocardiography.

  • TIA, transient ischaemic attack.